Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Nestlé S.A.    NESN   CH0038863350


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Nestle : makeover advances with $10 billion sale of skin health unit

share with twitter share with LinkedIn share with facebook
share via e-mail
05/16/2019 | 09:22am EST
FILE PHOTO: Logo is pictured during the 152nd Annual General Meeting of Nestle in Lausanne

ZURICH/FRANKFURT (Reuters) - Nestle has entered exclusive talks to sell its skin health business to a consortium led by EQT Partners for 10.2 billion Swiss francs ($10.1 billion), as the food group shifts its portfolio in response to changing consumer demands.

The proposed transaction with private equity firm EQT, a unit of the Abu Dhabi Investment Authority and PSP Investments is expected to close in the second half of 2019 pending regulatory approval, Nestle said on Thursday.

Nestle Chief Executive Mark Schneider put the skin health unit up for sale last September as the group moved to ditch underperforming businesses, following years of slowing growth as many consumers favored fresh foods over packaged goods.

Nestle was also under fire from activist investor Daniel Loeb's Third Point, which asked for a faster overhaul in July. The U.S. hedge fund has since generated very good returns on its Nestle stake, leading Loeb to praise Schneider's performance this year.

Nestle shares were up 0.8 percent at 1315 GMT, after hitting an all-time high earlier in the session following the announcement of the deal, which according to Refinitiv data is the second largest European private equity buyout since the financial crisis after Carlyle's acquisition of an Akzo Nobel unit last year.

Analysts said the price tag was attractive for Nestle at an enterprise value-to-sales multiple of 3.6 times, or a multiple of roughly 20 times expected core earnings.

The unit, which will be rebranded Galderma, is expected to post earnings before interest, tax, depreciation and amortization of roughly 550 million Swiss francs this year and of more than 600 million next year, a person close to the matter said.

"EQT focuses on quality businesses. We have a lot of good ideas how to develop Nestle Skin Health into a pearl and then make our return," EQT partner and co-head of private equity Marcus Brennecke told Reuters.

"We will strengthen Galderma's board with relevant industrial expertise to develop each of the three business units to their full potential. A couple of prescription drugs are theoretical blockbusters with large business opportunities," he said.


ZKB analyst Patrik Schwendimann estimated the transaction would generate an extraordinary gain before taxes of around 4 billion francs for Nestle based on the net book value of 6.2 billion francs Nestle gave the unit in its 2018 financial statements.

Nestle will provide an update on how it will use the proceeds and its future capital structure after the deal closes.

Schwendimann said Nestle was under no pressure to announce a new share buyback given that the current one runs until the end of the year.

Nestle Skin Health (NSH), which sells Cetaphil and Proactiv skin care products, Restylane wrinkle fillers and prescription dermatology medicines, had sales of 2.8 billion Swiss francs last year.

Nestle created the unit, which will remain headquartered in Switzerland, in 2014 when it bought L'Oreal's stake in their Galderma joint venture.

Under former Chief Executive Paul Bulcke, skin treatments were part of Nestle's push into higher-growth health products to counter a slowdown in its traditional food business, but performed poorly, leading to one-off costs and restructuring.

A reorganization over the last two and half years returned it to double-digit sales growth in the first quarter of 2019.

Schneider said in February that NSH was now "a leader in its space" with a competitive cost structure, and that suitors were lining up to acquire it.

"(This) looks like a very good piece of business for Nestle. Most probably assumed a price tag would be around 7 billion Swiss francs at the start of the process," said Jon Cox, analyst at Kepler Cheuvreux.

Vontobel's Jean-Philippe Bertschy said the disposal was the logical consequence of the sharper capital allocation introduced by Schneider.

EQT and ADIA, which are financing the deal through a roughly 50:50 split of equity and debt, had faced competition from rival buyout funds and industry players including a consortium of Advent and Cinven, as well as U.S. private equity firm KKR and European fund PAI Partners, sources had said.

Advisory firm Evercore and Credit Suisse advised Nestle on the deal, while EQT was advised by Rothschild, PWC and Kirkland & Ellis.

(Reporting by Silke Koltrowitz, Arno Schuetze, Michael Shields and Pamela Barbaglia; Editing by Brenna Hughes Neghaiwi and Jan Harvey)

By Silke Koltrowitz and Arno Schuetze

Stocks mentioned in the article
ChangeLast1st jan.
FORBO HOLDING AG 0.62% 1630 Delayed Quote.17.31%
NESTLÉ S.A. 1.33% 103.9 Delayed Quote.28.50%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on NESTLÉ S.A.
12/05Beyond Meat burgers to be sold at some Costco stores
12/05NESTLE S A : supports families with new parental leave policy
12/05NESTLE S A : DBRS Morningstar Confirms Nestle S.A. and Nestle Capital Canada Ltd..
12/04NESTLE S A : Barry Callebaut cites progress in helping cocoa farmers tackle chil..
12/04NESTLE S A : Nestlé supports families with new parental leave policy
12/02NESTLE S A : Purina announces the second BetterwithPets Prize
12/02Credit of Interim Cash Dividend of Nestle Pakistan Limited
11/28Nestle, Unilever, AB InBev Call For EU Laws on Zero-Emission Vehicles
11/27NESTLE S A : to use Nutri-Score nutrition-labelling in Europe
11/26Correction to article on consumer brands' plastic use
More news
Financials (CHF)
Sales 2019 93 216 M
EBIT 2019 16 458 M
Net income 2019 12 568 M
Debt 2019 27 624 M
Yield 2019 2,59%
P/E ratio 2019 24,5x
P/E ratio 2020 23,6x
EV / Sales2019 3,51x
EV / Sales2020 3,51x
Capitalization 300 B
Duration : Period :
Nestlé S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NESTLÉ S.A.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 111,57  CHF
Last Close Price 103,90  CHF
Spread / Highest target 17,4%
Spread / Average Target 7,39%
Spread / Lowest Target -15,3%
EPS Revisions
Ulf Mark Schneider Chief Executive Officer & Director
jeff hamilton President
Paul Bulcke Chairman
Magdi Batato Executive Vice President-Operations
François-Xavier Michel Marie Roger Chief Financial Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
NESTLÉ S.A.28.50%299 897
DANONE19.14%52 711
GENERAL MILLS, INC.38.42%32 577